1. Home
  2. TVTX vs LAUR Comparison

TVTX vs LAUR Comparison

Compare TVTX & LAUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$65.28

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Logo Laureate Education Inc.

LAUR

Laureate Education Inc.

HOLD

Current Price

$36.78

Market Cap

5.2B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
LAUR
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.2B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
TVTX
LAUR
Price
$65.28
$36.78
Analyst Decision
Strong Buy
Buy
Analyst Count
13
4
Target Price
$40.62
$39.63
AVG Volume (30 Days)
1.2M
809.5K
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
92.89
N/A
EPS
N/A
0.82
Revenue
N/A
$1,484,288,000.00
Revenue This Year
$44.76
$14.58
Revenue Next Year
$35.51
$7.85
P/E Ratio
N/A
$44.73
Revenue Growth
N/A
19.48
52 Week Low
$22.06
$24.98
52 Week High
$68.03
$40.93

Technical Indicators

Market Signals
Indicator
TVTX
LAUR
Relative Strength Index (RSI) 60.45 43.42
Support Level $53.76 $36.59
Resistance Level $66.24 $38.10
Average True Range (ATR) 1.98 0.97
MACD -0.14 -0.18
Stochastic Oscillator 71.85 31.27

Price Performance

Historical Comparison
TVTX
LAUR

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

About LAUR Laureate Education Inc.

Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its reportable segments include Peru and Mexico, of which Mexico derives maximum revenue. Geographically, the company operates in Mexico, Peru and United States.

Share on Social Networks: